相关实验视频

Updated: Jun 25, 2025

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

9.9K

对扩散型大B细胞淋巴瘤中MAPK12蛋白表达的临床病理特征和预后价值的回顾性分析

Yue Liu1, Han Zhang1, Shu Zhao2

  • 1Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|May 21, 2024
PubMed
概括

甲基因激活蛋白激酶12 (MAPK12) 的高水平与分散型大B细胞淋巴瘤 (DLBCL) 患者的预后不佳相关. MAPK12被确定为DLBCL的潜在治疗标和预后因素.

关键词:
扩散大的B细胞淋巴瘤.免疫组织化学 免疫组织化学在MAPK12中,您可以使用MAPK12.预测 预测 预测 预测

更多相关视频

Predictive Immune Modeling of Solid Tumors08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

6.9K
Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

6.7K

相关概念视频

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K